Skip to main content

Encapsulating Synthetic STING Agonist, MSA-2, in Endosomolytic Polymersomes for Cancer Immunotherapy

Utilization of STING agonist MSA-2 encapsulated nanocarriers to enhance the immune system’s ability to eliminate cancer cells.

Posted by buchanle on Wednesday, June 25th, 2025 in May 2025, , , , , ,

Read more


In Vitro Analysis of Synergy between Adjuvants MPLA, CpG, and cGAMP for Treatment of Cancer

Synergistic application of adjuvants was used to analyze interferon and NF-κB immunological responses in mouse macrophages for the treatment of cancer.

Posted by John Lee on Tuesday, December 22nd, 2020 in May 2019, , , ,

Read more